首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >Comparison of dexmedetomidine-propofol versus fentanyl-propofol for insertion of laryngeal mask airway
【24h】

Comparison of dexmedetomidine-propofol versus fentanyl-propofol for insertion of laryngeal mask airway

机译:右美托咪定-丙泊酚与芬太尼-丙泊酚插入喉罩气道的比较

获取原文
           

摘要

Background and aims: Laryngeal mask airway (LMA) insertion requires anesthesia and suppression of airway reflexes. In search of an optimal drug, we compared dexmedetomidine and fentanyl, in combination with propofol for insertion of LMA. Material and Methods: This study was a prospective double blind randomized study. Eighty patients of ASA class 1&2 were randomly divided into two groups of 40 each. Group D received dexmedetomidine 1 mcg/kg and group F received fentanyl 1 mcg/kg intravenously (IV) over 2 minutes. For induction, propofol 2mg/kg was given IV and 90 seconds later LMA was inserted. We observed apnea time, heart rate, respiratory rate, non invasive blood pressure and oxygen saturation before induction, 30 seconds after induction, 1, 3, 5, 10 and 15 minutes after insertion of LMA. Patient's response to LMA insertion like coughing, gagging or any movement were noted and scored. Statistical analysis of data was done using student t test for parametric data, Chi-square test for non parametric data and SPSS 15.0 for windows software. Results: 37 (92.5%) patients of group D and 35 (87.5%) patients of group F had LMA insertion score of 2. Adverse events to insertion of LMA and hemodynamic variables were comparable in both the groups. Number of patients developing apnoea was larger and apnoea times were longer in group F compared to group D. When compared to group F, group D showed an increased respiratory rate. Conclusion: Dexmedetomidine can be a comparable alternative to fentanyl as an adjuvant to propofol for providing optimum insertion conditions for LMA and preservation of respiration.
机译:背景与目的:插入喉罩气道(LMA)需要麻醉并抑制气道反射。为了寻找最佳药物,我们比较了右美托咪定和芬太尼与丙泊酚联合用于LMA的插入。材料与方法:本研究为前瞻性双盲随机研究。将ASA 1&2类的80名患者随机分为两组,每组40名。 D组在2分钟内静脉内(IV)接受右美托咪定1mcg / kg,F组接受芬太尼1mcg / kg。为了进行诱导,静脉内给予异丙酚2mg / kg,并在90秒后插入LMA。我们观察到呼吸暂停时间,心率,呼吸频率,诱导前,诱导后30秒,插入LMA后1、3、5、10和15分钟的无创血压和血氧饱和度。记录并记分患者对LMA插入的反应,例如咳嗽,呕吐或任何运动。数据的统计分析是使用学生t检验(用于参数数据),卡方检验(用于非参数数据)和SPSS 15.0(对于Windows软件)进行的。结果:D组的37名患者(92.5%)和F组的35名患者(87.5%)的LMA插入得分为2。两组的LMA插入不良事件和血液动力学变量均相当。与D组相比,F组发生呼吸暂停的患者人数更多,呼吸暂停时间更长。与F组相比,D组呼吸频率增加。结论:右美托咪定可以代替芬太尼作为丙泊酚的佐剂,从而为LMA提供最佳的插入条件并保持呼吸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号